Do you encounter parents who are concerned about the “newness” of a vaccine or find yourself having to explain changes to vaccine recommendations? Find useful tools about vaccine development and timeline questions.

Read about Pfizer’s and GSK’s RSV vaccine trials in pregnant people and why only Pfizer submitted their vaccine for review.

Published by the National Academy of Sciences, this report offers important context and considerations for communicating about health- and science-related topics in today’s environment.

Check out three publications for insights into what the public thinks about science, how the COVID-19 pandemic changed the situation, and how these perceptions can influence health-related decision-making.

Dr. Offit explains that one of the influenza type B strains has disappeared from circulation. For this reason, 2024-2025 influenza vaccines will contain only three types of influenza strains.

Dr. Paul Offit talks about spring 2024 changes to the isolation recommendations for those with COVID-19.

Dr. Paul Offit talks about an update to the 2023-2024 COVID-19 booster recommendations and who is most likely to benefit from two boosters during a single year.

Pilot study reveals early evidence of efficacy of a pharmacologic treatment for concussion, as patients experienced faster symptom reduction and return to physical activity

A metabolite called NAD encourages immune cells to divide more quickly and could be used to improve efficacy of cell-based therapies.

On Saturday, March 9 and Sunday, March 10, more than 200 teams rode for little hearts at the eighth annual Philly Spin-In, raising funds and awareness for cardiac care and research.